Cellular Biomedicine Group, Inc. Purchase Agreements
10 Contracts & Agreements
- Securities Purchase Agreement, dated September 25, 2018, by and among the Company, Novartis Pharma AG and Shanghai Cellular Biopharmaceutical Group Ltd (Filed With SEC on September 27, 2018)
- AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)
- AMENDMENT NO. 1 TO REGISTRATION PURCHASE AGREEMENT (Filed With SEC on February 7, 2018)
- SECURITIES PURCHASE AGREEMENT BY AND AMONG CELLULAR BIOMEDICINE GROUP, INC., WEALTH MAP HOLDINGS LIMITED, EARLS MILL LIMITED, AND BOSUN S. HAU JANUARY 30, 2018 TABLEOF CONTENTS (Filed With SEC on January 31, 2018)
- SHARES PURCHASE AGREEMENT (Filed With SEC on February 10, 2016)
- Asset Purchase Agreement, dated June 8, 2015 (Filed With SEC on July 2, 2015)
- ASSET PURCHASE AGREEMENT by and among BLACKBIRD BIOFINANCE, LLC, as Seller, DR. SCOTT ANTONIA and SAM SHRIVASTAVA as Principals, CELLULAR BIOMEDICINE GROUP, INC. as Parent,... (Filed With SEC on June 12, 2015)
- U.S. Patent Purchase Agreement, dated September 26, 2014 (Filed With SEC on October 2, 2014)
- SECURITIES PURCHASE AGREEMENT Dated as of December 17, 2012 by and between Eastbridge Investment Group Corp. and Zhang, Hui and MA Platform, Inc. (Filed With SEC on June 18, 2013)
- Securities Purchase Agreement by and among the Company, Hui Zhang and MA Platform, Inc., dated December 17, 2012 (Filed With SEC on January 14, 2013)